Back to Speakers

Glennis Mehra, Ph.D.

Glennis Mehra, Ph.D.

Director

BioLabs@NYULangone

Dr. Mehra is the Executive Director of BioLabs@NYULangone. She is an accomplished serial entrepreneur, business consultant, and angel investor with proven success in a variety of geographies and industries. Her experience spans teaching, biotechnology (biotech), technology transfer, international business operations, research and development, functional genomics, and consumer product development and insights.

Throughout her career, she has gravitated toward emerging technologies and businesses. As one of the early adopters of functional genomic tools during doctoral work at Columbia University, she performed one of the first high-content gene expression profiles and analysis of damaged and regenerating epithelium. After earning her Ph.D. in Neurobiology & Behavior from Columbia University, she joined the university's technology ventures group, where she created IP strategies and valuation systems and helped commercialize technologies from the biology and chemistry departments. From there, she co-founded and ran two successful startups in India before partnering with SPRIM Strategy and Innovation Consulting to provide a startup perspective to multinational/Fortune 500 companies.

Content Where I Am Featured

Sort By
Search by Keyword
  • Contains 1 Component(s), Includes Credits

    The life sciences sector that exploded during the pandemic has settled back down to earth as what Commercial Observer describes as "a more mature version of itself." Nevertheless, the prospects for future growth in this critical industry remain strong, and its unique real estate requirements have prompted the emergence of a new space typology. Existing at the convergence of academic and corporate methodologies, life sciences enterprises require real estate strategies that merge the infrastructure required to support technologically advanced research with high-performance interiors. When these strategies are most effective, these spaces will drive innovation and support a sense of purpose among their users, and ultimately set standards for efficiency and productivity. These standards will be critical for profit-driven business models in an intensely competitive industry sector. In moderated dialog a practitioner focused on design for life sciences and an end user from a life sciences R&D facility will discuss real estate strategies in the life sciences sector and the design trends taking shape to support the next generation of science. Panelists will explore best practices for life sciences facilities through the lenses of three current trends--wellness, sustainability and technology--that are increasingly informing the design of these technically complex building types.